Finland – Antivirals for systemic use – Baloxavir marboxil 40 mg tabletit
Terveyden ja hyvinvoinnin laitos awarded €4.1M to Roche Oy for Professional Services & Consulting in January 2025 — one of 120 awards this buyer has made, above its typical award size.
Buying agency
Terveyden ja hyvinvoinnin laitosWinning supplier
Roche OyContract description
Finland – Antivirals for systemic use – Baloxavir marboxil 40 mg tabletit
Related awards · Terveyden ja hyvinvoinnin laitos
120 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-712730-2024Arthrone Oy€3.7M22 Nov 2024 Healthcare
- ocds-ted-713154-2024Viatris Oy€3.0M22 Nov 2024 Healthcare
- ocds-ted-518586-2025Fabentech SA€2.8M07 Aug 2025 Professional Services
Other wins · Roche Oy
4 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-289483-2026Pirkanmaan hyvinvointialue€1.0M28 Apr 2026 Healthcare
- ocds-ted-275726-2026-7Sansia OyNot disclosed22 Apr 2026 Healthcare
- ocds-ted-337735-2025-5Sansia OyNot disclosed26 May 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Terveyden ja hyvinvoinnin laitos and Roche Oy — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back